J. Jaime
Impact in
- Hematology top 0.1%
- Erythropoietin and Anemia Treatment
- Iron Metabolism and Disorders
- Family Practice top 0.2%
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 77
- Pharmaceutical Economics and Policy 24
- Hematology 64
- Erythropoietin and Anemia Treatment 45
- Iron Metabolism and Disorders 17
- Co-authors
- Susana Alicia Salceda (6 shared papers)Scott Haldeman (2 shared papers)Simon Dagenais (2 shared papers)Maribel Salas (15 shared papers)Judith A. O’Brien (29 shared papers)Krista F. Huybrechts (20 shared papers)О. H. Minchenko (12 shared papers)K. Jack Ishak (21 shared papers)
- Journals
- Value in Health (32 papers)PharmacoEconomics (22 papers)Blood (14 papers)Clinical Therapeutics (12 papers)Journal of Biological Chemistry (11 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
J. Jaime
368 papers receiving 23.1k citations
J. Jaime's Hit Papers
Peers
Comparison fields: 5 of 199
- Hematology 3.4k
- Family Practice 668
- Cancer Research 4.2k
- Geriatrics and Gerontology 719
- Genetics 1.6k
Countries citing papers authored by J. Jaime
This map shows the geographic impact of J. Jaime's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Jaime with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Jaime more than expected).
Fields of papers citing papers by J. Jaime
This network shows the impact of papers produced by J. Jaime. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Jaime. The network helps show where J. Jaime may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Jaime, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 383 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A systematic review of low back pain cost of illness studies in the United States and internationally Hit paper breakdown → | 2008 | 1540 |
| 2 | Hypoxia-inducible Factor 1α (HIF-1α) Protein Is Rapidly Degraded by the Ubiquitin-Proteasome System under Normoxic Conditions Hit paper breakdown → | 1997 | 1406 |
| 3 | Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force Hit paper breakdown → | 2013 | 739 |
| 4 | Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Hit paper breakdown → | 2001 | 693 |
| 5 | Anemia as an independent prognostic factor for survival in patients with cancer Hit paper breakdown → | 2001 | 599 |
| 6 | Model Transparency and Validation Hit paper breakdown → | 2012 | 595 |
| 7 | Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1 Hit paper breakdown → | 2012 | 524 |
| 8 | Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis Hit paper breakdown → | 2007 | 520 |
| 9 | 2004 | 389 | |
| 10 | Modeling Good Research Practices—Overview Hit paper breakdown → | 2012 | 364 |
| 11 | Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. | 1994 | 360 |
| 12 | 2010 | 352 | |
| 13 | Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7 Hit paper breakdown → | 2012 | 348 |
| 14 | 2003 | 301 | |
| 15 | 2002 | 297 | |
| 16 | 2005 | 293 | |
| 17 | 2007 | 266 | |
| 18 | 2012 | 262 | |
| 19 | Persistence with treatment for hypertension in actual practice. | 1999 | 257 |
| 20 | 2014 | 251 |
About J. Jaime
J. Jaime is a scholar working on Economics and Econometrics, Hematology, Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology, having authored 383 papers that have together received 24.1k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (77 papers), Erythropoietin and Anemia Treatment (45 papers), Cancer, Hypoxia, and Metabolism (38 papers), Hemoglobinopathies and Related Disorders (28 papers), Pharmaceutical Economics and Policy (24 papers), Erythrocyte Function and Pathophysiology (22 papers), Metabolism, Diabetes, and Cancer (18 papers) and Iron Metabolism and Disorders (17 papers). The work is most often cited by research in Hematology (3.4k citations), Family Practice (668 citations), Cancer Research (4.2k citations), Geriatrics and Gerontology (719 citations) and Genetics (1.6k citations). J. Jaime has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Susana Alicia Salceda, Scott Haldeman, Simon Dagenais, Maribel Salas, Judith A. O’Brien, Krista F. Huybrechts, О. H. Minchenko, K. Jack Ishak, Glenwood Goss and Alexandra M. Ward. Their work appears in journals such as Value in Health, PharmacoEconomics, Blood, Clinical Therapeutics and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.